Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369428
Status:
COMPLETED
Last Update Posted:
2024-04-17
First Post:
2024-04-11
Brief Title:
Patient Characteristics Treatment Patterns and Healthcare Resource Utilization of Metastatic Melanoma Patients
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Non-interventional Register-based Study to Analyze Patient Characteristics Treatment Patterns and Healthcare Resource Utilization in Adult Patients With Metastatic Melanoma
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This was a retrospective non-interventional registry study based on secondary electronic medical record EMR data collected in Helsinki and Uusimaa hospital district HUS data lake hospital district of Southwest Finland VSSHP data lake and Pirkanmaa hospital district PSHP data lake as a part of their routine clinical practice Social Insurance Institution of Finland SII reimbursed drug purchases was utilized in this study to complement the medication data The metastatic melanoma patients were stratified by first-line treatment and by hospital district
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None